Longboard Pharmaceuticals Inc
General ticker "LBPH" information:
- Sector: Health Care
- Industry: Pharmaceuticals
- Capitalization: $2.3B
Longboard Pharmaceuticals Inc follows the US Stock Market performance with the rate: 47.5%.
Estimated limits based on current volatility of 0.0%: low 59.96$, high 59.98$
Factors to consider:
- Earnings for 18 months up through Q2 (+1 year) are close to our estimates
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2022-12-31 to 2024-12-30
- 2022-12-31 to 2023-12-31 estimated range: [2.40$, 4.58$]
- 2023-12-31 to 2024-12-30 estimated range: [2.06$, 4.04$]
Short-term LBPH quotes
Long-term LBPH plot with estimates
Financial data
| YTD | 2021-12-31 | 2022-12-31 | 2023-12-31 |
|---|---|---|---|
| Operating Revenue | $0.00MM | $0.00MM | $0.00MM |
| Operating Expenses | $27.84MM | $44.80MM | $56.76MM |
| Operating Income | $-27.84MM | $-44.80MM | $-56.76MM |
| Non-Operating Income | $-0.12MM | $0.33MM | $2.34MM |
| Interest Expense | $0.00MM | $0.84MM | $0.00MM |
| R&D Expense | $19.77MM | $34.64MM | $43.75MM |
| Income(Loss) | $-27.96MM | $-44.47MM | $-54.42MM |
| Profit(Loss) | $-27.96MM | $-44.47MM | $-54.42MM |
| Stockholders Equity | $103.32MM | $61.47MM | $40.92MM |
| Assets | $108.95MM | $70.62MM | $50.70MM |
| Operating Cash Flow | $-24.70MM | $-38.06MM | $-50.87MM |
| Capital expenditure | $0.02MM | $0.00MM | $0.00MM |
| Investing Cash Flow | $-40.72MM | $-17.06MM | $24.23MM |
| Financing Cash Flow | $76.45MM | $-0.44MM | $30.19MM |
| Earnings Per Share* | $-1.62 | $-2.51 | $-2.39 |
* EPS are Split Adjusted, recent splits may be reflected with a delay.